128 related articles for article (PubMed ID: 15008244)
1. Recombinant monoclonal thyrotropin-stimulation blocking antibody (TSBAb) established from peripheral lymphocytes of a hypothyroid patient with primary myxedema.
Moriyama K; Okuda J; Saijo M; Hattori Y; Kanamoto N; Hataya Y; Matsuda F; Mori T; Nakao K; Akamizu T
J Endocrinol Invest; 2003 Nov; 26(11):1076-80. PubMed ID: 15008244
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
[TBL] [Abstract][Full Text] [Related]
3. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
[TBL] [Abstract][Full Text] [Related]
4. Growth stimulating antibody, as another predisposing factor of Graves' disease (GD): analysis using monoclonal TSH receptor antibodies derived from patients with GD.
Ihara Y; Kanda Y; Seo M; Watanabe Y; Akamizu T; Tanaka Y
Endocr J; 2012; 59(7):571-7. PubMed ID: 22510947
[TBL] [Abstract][Full Text] [Related]
5. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
6. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema.
Okuda J; Akamizu T; Sugawa H; Matsuda F; Hua L; Mori T
J Clin Endocrinol Metab; 1994 Dec; 79(6):1600-4. PubMed ID: 7989462
[TBL] [Abstract][Full Text] [Related]
8. Sensitive assay to detect thyroid stimulating antibody (TSAb) in the presence of thyroid stimulation blocking antibody (TSBAb) in serum.
Ochi Y; Yamashiro K; Takasu N; Kajita Y; Sato Y; Nagata A
Horm Metab Res; 2001 Feb; 33(2):115-20. PubMed ID: 11294493
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
10. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema.
Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Urayama S; Kawabe Y; Tahara K; Ishikawa N; Ito K; Nagataki S
Clin Exp Immunol; 1997 Dec; 110(3):434-9. PubMed ID: 9409648
[TBL] [Abstract][Full Text] [Related]
12. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
Ueta Y; Fukui H; Murakami H; Yamanouchi Y; Yamamoto R; Murao A; Santou Y; Taniguchi S; Mitani Y; Shigemasa C
Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319
[TBL] [Abstract][Full Text] [Related]
13. Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Nakazato N; Tani J; Abe K
Clin Endocrinol (Oxf); 1998 Jan; 48(1):17-22. PubMed ID: 9509063
[TBL] [Abstract][Full Text] [Related]
14. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
16. Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease.
Shin EK; Akamizu T; Matsuda F; Sugawa H; Fujikura J; Mori T; Honjo T
J Immunol; 1994 Feb; 152(3):1485-92. PubMed ID: 8301147
[TBL] [Abstract][Full Text] [Related]
17. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema.
Kamath C; Young S; Kabelis K; Sanders J; Adlan MA; Furmaniak J; Rees Smith B; Premawardhana LD
Clin Endocrinol (Oxf); 2012 Sep; 77(3):465-70. PubMed ID: 22891608
[TBL] [Abstract][Full Text] [Related]
18. Discrete characteristics of antibodies raised against thyrotropin receptor-related peptides whose sequences are not conserved in the luteinizing hormone/chorionic gonadotropin receptor.
Murakami M; Miyashita K; Mizuma H; Yamada M; Iriuchijima T; Takeuchi T; Mori M
J Clin Endocrinol Metab; 1996 May; 81(5):1747-52. PubMed ID: 8626828
[TBL] [Abstract][Full Text] [Related]
19. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
20. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Ochi Y; Kajita Y; Hamazu M; Nagata A
Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
